PROPYLTHIOURACIL

Clinical safety rating: avoid

Other bone marrow suppressants may increase risk of agranulocytosis Can cause agranulocytosis and hepatotoxicity.

How it works

Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.

Tablet 50 mg - Oral

Dosage form	TABLET
Renal impairment	Consult protocols for adjustment.
Liver impairment	Consult protocols for adjustment.

Clinical note

Other bone marrow suppressants may increase risk of agranulocytosis Can cause agranulocytosis and hepatotoxicity.

FDA category

Category Positive

arthralgia

Loading safety data…

Clinical safety rating: avoid

Other bone marrow suppressants may increase risk of agranulocytosis Can cause agranulocytosis and hepatotoxicity.

Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.

Tablet 50 mg - Oral

Dosage form	TABLET
Renal impairment	Consult protocols for adjustment.
Liver impairment	Consult protocols for adjustment.

Clinical note

Other bone marrow suppressants may increase risk of agranulocytosis Can cause agranulocytosis and hepatotoxicity.

FDA category

Category Positive

arthralgia

Loading safety data…